⌘K

Login Start Free

Home/Filings/5/0000950170-25-010530

5//SEC Filing

Wilson Marc 5

Accession 0000950170-25-010530

CIK 0001658247other

View on SEC.gov Company Profile

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 4:30 PM ET

Size

4.7 KB

Accession

0000950170-25-010530

Insider Transaction Report

Form 5

Period: 2024-12-31

Crinetics Pharmaceuticals, Inc.CRNX

CFO

Transactions

Other
Common Stock
2024-11-20$14.98/sh+473$7,086→ 111,565 total

Footnotes (1)

[F1]Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),

Documents

1 file

5
ownership.xmlPrimary
5

Issuer

Crinetics Pharmaceuticals, Inc.

CIK 0001658247

Entity typeother

Related Parties

1

filerCIK 0001702265

Filing Metadata

Form type: 5
Filed: Jan 28, 7:00 PM ET
Accepted: Jan 29, 4:30 PM ET
Size: 4.7 KB

View on SEC.gov